Nasal Symptoms in Asthmatic Patients under Treatment with Anti-IL-5 Monoclonal Antibodies. A Real-Life Cohort Study

Currently, some monoclonal antibodies (mAbs) are being studied for chronic rhinosinusitis with nasal polyps (CRSwNP). Three anti-IL-5 mAb: mepolizumab, reslizumab and benralizumab, have been tested through randomized clinical trials. In this real-life study, we aimed to describe the nasal effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Maza-Solano, Juan, Calvo-Henríquez, Christian, Alobid, Isam, Álvarez-Cendrero, Marta, Palomares, Óscar, Moreno-Luna, Ramón, Santos-Perez, Jaime, González-García, Jaime, Sánchez-Gómez, Serafín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740481/
https://www.ncbi.nlm.nih.gov/pubmed/36498632
http://dx.doi.org/10.3390/jcm11237056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740481/
https://www.ncbi.nlm.nih.gov/pubmed/36498632
http://dx.doi.org/10.3390/jcm11237056

Ejemplares similares